Holen Sie sich die Stockscreener-App
26.43
1.26%
0.33
Vorhandelsmarkt:
26.37
-0.06
-0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt PFE?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$26.10
Offen:
$26.055
24-Stunden-Volumen:
47.31M
Relative Volume:
1.26
Marktkapitalisierung:
$149.78B
Einnahmen:
$63.63B
Nettoeinkommen (Verlust:
$8.03B
KGV:
18.74
EPS:
1.41
Netto-Cashflow:
$9.84B
1W Leistung:
+0.49%
1M Leistung:
-0.34%
6M Leistung:
-8.89%
1J Leistung:
-0.49%
1-Tages-Spanne:
$25.91
$26.49
1-Wochen-Bereich:
$25.88
$27.03
52-Wochen-Spanne:
$24.48
$31.54
Pfizer Inc Stock (PFE) Company Profile
Firmenname
Pfizer Inc
Sektor
Telefon
(212) 733-2323
Adresse
66 HUDSON BOULEVARD EAST, NEW YORK, NY
Vergleichen Sie PFE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PFE
Pfizer Inc
|
26.43 | 149.78B | 63.63B | 8.03B | 9.84B | 1.41 |
|
LLY
Lilly Eli Co
|
920.63 | 874.97B | 45.04B | 10.59B | 414.30M | 11.71 |
|
NVO
Novo Nordisk Adr
|
90.65 | 402.40B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
ABBV
Abbvie Inc
|
209.03 | 369.01B | 56.33B | 4.28B | 17.83B | 2.40 |
|
JNJ
Johnson Johnson
|
165.02 | 344.63B | 88.82B | 14.07B | 18.06B | 5.79 |
|
MRK
Merck Co Inc
|
92.25 | 251.88B | 64.17B | 17.12B | 18.10B | 6.73 |
Pfizer Inc Stock (PFE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
| 2024-11-15 | Eingeleitet | Wolfe Research | Underperform |
| 2024-10-25 | Fortgesetzt | Citigroup | Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-08-07 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2024-03-22 | Herabstufung | Argus | Buy → Hold |
| 2024-02-23 | Eingeleitet | Guggenheim | Buy |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-10-20 | Fortgesetzt | UBS | Neutral |
| 2023-10-16 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-17 | Bestätigt | JP Morgan | Neutral |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-06-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-11 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2023-03-06 | Eingeleitet | Jefferies | Hold |
| 2023-02-07 | Hochstufung | Daiwa Securities | Neutral → Outperform |
| 2023-01-26 | Herabstufung | UBS | Buy → Neutral |
| 2023-01-17 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-12-13 | Hochstufung | Goldman | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-01-03 | Bestätigt | Bernstein | Mkt Perform |
| 2021-12-20 | Bestätigt | Cowen | Outperform |
| 2021-12-17 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Outperform |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-06 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-02-04 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-12-16 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-11-19 | Fortgesetzt | Goldman | Neutral |
| 2020-11-10 | Fortgesetzt | Bernstein | Mkt Perform |
| 2020-10-12 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-06-16 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-02-27 | Hochstufung | Standpoint Research | Hold → Buy |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-07-30 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-04 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-02-20 | Fortgesetzt | Citigroup | Neutral |
| 2019-01-31 | Hochstufung | Argus | Hold → Buy |
| 2019-01-31 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-01-23 | Herabstufung | UBS | Buy → Neutral |
| 2018-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-11-01 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
Alle ansehen
Pfizer Inc Aktie (PFE) Neueste Nachrichten
Pfizer's Abrysvo Gets Positive CHMP Opinion For Adults Aged 18 To 59 -March 03, 2025 at 04:43 am EST - Marketscreener.com
Ataxia Market Is Booming Worldwide 2025-2032 | Pfizer, Inc., - openPR
Call for Collaborator(s): Pfizer RSVOA Research - fundsforNGOs
Is Pfizer Inc. (PFE) the Best Weight Loss Drug Stock to Buy According to Analysts? - Yahoo Finance UK
2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Now - The Motley Fool
Is Pfizer Inc. (PFE) the Best Affordable Dividend Stock to Buy According to Hedge Funds? - Insider Monkey
Chase Investment Counsel Corp Trims Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
US Bancorp DE Sells 491,587 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Fisher Asset Management LLC Buys 4,938,209 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
SVB Wealth LLC Invests $13.87 Million in Pfizer Inc. (NYSE:PFE) - MarketBeat
Mutual of America Capital Management LLC Reduces Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Private Trust Co. NA - MarketBeat
Pfizer Inc. (NYSE:PFE) Stake Lowered by NewEdge Wealth LLC - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Oppenheimer Asset Management Inc. - MarketBeat
What is Zacks Research's Estimate for Pfizer Q3 Earnings? - MarketBeat
Blackhawk Capital Partners LLC. Sells 9,930 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Impax Asset Management Group plc Makes New $713,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat
National Pension Service Has $314.54 Million Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer Inc. (NYSE:PFE) Shares Sold by Sabal Trust CO - MarketBeat
Commonwealth Retirement Investments LLC Lowers Holdings in Pfizer Inc. (NYSE:PFE) - MarketBeat
Bank of New York Mellon Corp Has $1.06 Billion Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Delta Financial Advisors LLC Decreases Stock Position in Pfizer Inc. (NYSE:PFE) - MarketBeat
Amalgamated Bank Sells 28,055 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat
Pfizer (NYSE:PFE) Stock Price Down 0.4%What's Next? - MarketBeat
Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president - The Cancer Letter
Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds? - Insider Monkey
Pfizer quietly made some big DEI changes - Yahoo Finance
Covid Products Drove Pfizer's Fourth Quarter. Is It Now A Buy? - Investor's Business Daily
What’s next after Pfizer’s gene therapy for hemophilia B is halted? - Hemophilia News Today
Pfizer discontinues hemophilia B treatment Beqvez - Hemophilia News Today
EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years - Marketscreener.com
Turbulence at the FDA & bluebird Bio’s sale - STAT
Pfizer Drops Approved Hemophilia B Gene Therapy - MD Magazine
Pfizer is latest Big Pharma to overhaul DEI goals after GSK - Seeking Alpha
Pfizer Updates DEI Webpage to Focus on Merit -February 28, 2025 at 06:50 am EST - Marketscreener.com
Market Still Lacking Some Conviction On Pfizer Inc. (NYSE:PFE) - Simply Wall St
Spinal Cord Injury Therapeutics Market Projected To Witness Substantial Growth, 2025-2032: AbbVie Inc, Pfizer - EIN News
Is Pfizer Inc. (PFE) the Best Retirement Stock to Buy According to Hedge Funds? - Insider Monkey
Pfizer’s bet on gene therapies in haemophilia has been a bust - Yahoo Finance
Is Pfizer Inc. (PFE) the Best Stock Under $50 to Buy Right Now? - Insider Monkey
Trump Team Weighs Pulling Funds for Moderna Bird Flu Vaccine - Yahoo Finance
Activist Starboard Trailed Peers With Less Than 5% Returns - MSN
INVESTIGATION ALERT: Berger Montague PC Investigates Pfizer Inc.'s Board Of Directors For Breach of Fiduciary Duties (PFE) - TradingView
Fast Melt Tablets Market Detailed In New Research Report 2025 | Pfizer Inc., GlaxoSmithKline plc, Johnson & Johnson - openPR
Megyn Kelly claims Pfizer COVID vaccine left her with autoimmune condition: ‘Wish I hadn’t done it’ - New York Post
The Escalator: Pfizer, GSK, LiveWorld and more - MM+M Online
Haleon PLC Announces Shareholder Structure Change with Pfizer’s Conversion - TipRanks
Incretin Mimetics Market Deep Research and Growth by 2032: AstraZeneca, Pfizer Inc, Bristol-Myers Squibb Company, - openPR
Minoxidil Market Size, Industry Growth, Share & Analysis - openPR
Bernstein cuts Pfizer stock target to $30, keeps Market Perform By Investing.com - Investing.com South Africa
Bernstein cuts Pfizer stock target to $30, keeps Market Perform - Investing.com India
Finanzdaten der Pfizer Inc-Aktie (PFE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):